Left atrial appendage occlusion plus oral anticoagulation in stroke patients despite ongoing anticoagulation: the ADD-LAAO clinical trial
This study is one of the first randomized clinical trials to compare the LAAO plus OAC combination and optimal medical therapy in patients who have experienced ischemic strokes despite being on OAC. If results confirm the superiority of LAAO plus OAC, it could lead to a paradigm shift in treatment guidelines for these patients.
Authors
- Rodrigo Estévez-Loureiro
- Eduardo Flores‐Umanzor (ORCID: https://orcid.org/0000-0002-6428-241X)
- Xavier Millán (ORCID: https://orcid.org/0000-0001-6519-4190)
- Pedro Luis Cepas Guillén (ORCID: https://orcid.org/0000-0001-8814-7039)
- Luis López-Mesonero
- Xavier Freixa (ORCID: https://orcid.org/0000-0002-3203-9060)
- José Maciñeiras
- Patricia Simal (ORCID: https://orcid.org/0000-0002-5555-5308)
- Dabit Arzamendi (ORCID: https://orcid.org/0000-0001-7543-5867)
- Ignacio Cruz‐González (ORCID: https://orcid.org/0000-0001-9742-6072)
- Sergio Amaro (ORCID: https://orcid.org/0000-0001-6838-6390)
- Luis Nombela-Franco y (ORCID: https://orcid.org/0000-0003-3438-8907)
- Luís Prats‐Sánchez (ORCID: https://orcid.org/0000-0002-3192-4631)
- Luís Teruel
- Pere Cardona
Institutions
- Hospital de Sant Pau (ES)
- Bellvitge University Hospital (ES)
- University Hospital Complex Of Vigo (ES)
- Hospital Clínico San Carlos (ES)
- Complejo Hospitalario de Salamanca (ES)
- Hospital Clínic de Barcelona (ES)
Publication Details
- Journal
- REC interventional cardiology (English Edition)
- Published
- 2025-05-14
- DOI
- https://doi.org/10.24875/recice.m25000507
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00